MRT Inc. (JP:6034)

:6034

6034

MRT Inc.

RESEARCH TOOLSreports

Want to see JP:6034 full AI Analyst Report?

MRT Inc. (6034) Price & Analysis

1 Followers

6034 Stock Chart & Stats

¥630.00

¥6.00(0.85%)

At close: Jan 08 4:00 PM EST

¥630.00

¥6.00(0.85%)

Day’s Range― - ―

52-Week Range¥609.00 - ¥828.00

Previous CloseN/A

Volume6.60K

Average Volume (3M)6.11K

Market Cap

¥3.55B

Enterprise Value¥2.76B

Total Cash (Recent Filing)¥1.24B

Total Debt (Recent Filing)¥511.60M

Price to Earnings (P/E)―

Beta0.10

Next Earnings

Aug 07, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)14.12

Shares Outstanding5,718,600

10 Day Avg. Volume13,250

30 Day Avg. Volume6,110

Financial Highlights & Ratios

PEG Ratio-0.54

Price to Book (P/B)0.76

Price to Sales (P/S)0.84

P/FCF Ratio8.57

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

High Gross Margin (~62%)A sustained gross margin near 62% indicates meaningful product or service-level pricing power and structural cost advantages versus peers. That margin headroom supports durable operating cash flow even when top-line growth softens, enabling reinvestment and resilience over a 2–6 month horizon.

Conservative Leverage (D/E ~0.11)Very low debt-to-equity provides balance-sheet stability and financial flexibility, lowering refinancing and solvency risk. This structural conservatism allows the company to fund operations, pursue opportunistic investments, or withstand cyclical downturns without pressuring cash flow or requiring urgent capital raises.

Strong Cash Conversion (FCF ~95% Of NI)Free cash flow closely tracking net income signals high earnings quality and real cash generation capability. Reliable cash conversion underpins sustainable operational funding, reduces reliance on external financing, and supports long-term strategic initiatives, even if revenue growth is uneven.

Bears Say

Thin Net Profitability (~2% Margin)Very low net and operating margins constrain the company's ability to translate revenue into shareholder returns. Structural margin weakness reduces retained earnings for reinvestment, limits buffer against cost inflation, and makes sustained ROE improvement challenging absent meaningful operating leverage or revenue stabilization.

Volatile Revenue TrajectoryPersistent revenue volatility indicates inconsistent demand, possible customer concentration, or product-cycle sensitivity. That unpredictability undermines capacity planning and long-term investment decisions, making margin expansion and reliable free cash flow generation harder to sustain across business cycles.

Historic Cash-flow Volatility & Recent DeclineEpisodes of negative operating and free cash flow, plus a recent decline, highlight structural risk to cash sustainability. This history raises the likelihood that funding needs could recur under stress, constraining capital allocation and increasing the importance of conservative balance-sheet management to maintain long-term operations.

6034 FAQ

What was MRT Inc.’s price range in the past 12 months?

MRT Inc. lowest stock price was ¥609.00 and its highest was ¥828.00 in the past 12 months.

What is MRT Inc.’s market cap?

MRT Inc.’s market cap is ¥3.55B.

When is MRT Inc.’s upcoming earnings report date?

MRT Inc.’s upcoming earnings report date is Aug 07, 2026 which is in 80 days.

How were MRT Inc.’s earnings last quarter?

MRT Inc. released its earnings results on May 15, 2026. The company reported -¥14.45 earnings per share for the quarter, missing the consensus estimate of N/A by -¥14.45.

Is MRT Inc. overvalued?

According to Wall Street analysts MRT Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does MRT Inc. pay dividends?

MRT Inc. pays a Notavailable dividend of ¥30 which represents an annual dividend yield of N/A. See more information on MRT Inc. dividends here

What is MRT Inc.’s EPS estimate?

MRT Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does MRT Inc. have?

MRT Inc. has 5,718,600 shares outstanding.

What happened to MRT Inc.’s price movement after its last earnings report?

MRT Inc. reported an EPS of -¥14.45 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.274%.

Which hedge fund is a major shareholder of MRT Inc.?

Currently, no hedge funds are holding shares in JP:6034

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

MRT Inc.

MRT Inc. operates a medical information platform. The company provides temporary and part-time doctor services; doctor's career change support service; Door., an app to connect network of doctors; Door.into, which provides online health counseling, and online medical care; Pocket Doctor, a telemedicine/health consultation app; groupware for medical offices; FASTCALL that consolidates the functions required for hospital crisis management system as safety confirmation service for medical institution; and Good Doctors, which provides owned media sent by doctors. It also offers nurse and pharmacist recruitment service; human resources introduction service for clinical laboratory engineers, radiologists, and dialysis nurses, as well as for new business openings and succession projects; and recruitment information service for exclusive industrial physicians and contract industrial physicians. In addition, the company engages in employment agency business, opening of business, business succession support business, and PR business, and career support business. Further, it offers services for supporting the operation of medical institutions, such as fund management, utilizing medical fee factoring, payroll calculation for doctors' part-time jobs, and payroll transfer agency services. Additionally, the company sells human umbilical cord-derived stem cell culture supernatant; and provides babysitter services, tax accountant referral service, credit card payment agency service, questionnaire survey request for pharmaceuticals, etc., as well as media coverage cooperation, lecture request, event rescue, etc. It also publishes books on illness and treatment; and offers health maintenance service and member comprehensive compensation systems. The company was formerly known as Medical Research and Technology Co., Ltd and changed its name to MRT Inc. in September 2014. MRT Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.